Dolby Laboratories Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $75.54 High: $76.69
on July 30, 2025

52 Week Range

Low: $66.35 High: $89.66
on August 12, 2024
on January 30, 2025

All-Time High: $104.74 on May 3, 2021

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $7.3B
EPS i 2.64
P/E Ratio (TTM) i 28.86
Forward P/E i 20.00
P/B Ratio i 2.84
PEG Ratio i 20.00
Div. Yield i N/A
ROE i 10.31%
Beta i 0.908
Debt to Equity i 1.57

Financial Highlights

Profitability

Gross Margin i 90.30%
Operating Margin i 30.30%
Profit Margin i 19.44%

Returns and Earnings

Return on Assets (TTM) i 5.64%
Return on Equity (TTM) i 10.31%
EBITDA i $390.4M
Net Income (TTM) i $256.6M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i $13.84
Quarterly Revenue Growth (YoY) i 1.40%
Quarterly Earnings Growth (YoY) i -6.20%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Dolby Laboratories DLB 7.34B Mid-cap-1.38%1.98%-1.38%-13.27%-2.65%-0.67%-3.44%7.92%
Cintas CTAS 89.41B Large-cap0.87%0.12%5.41%10.36%22.54%17.94%110.70%187.91%
Copart CPRT 44.56B Large-cap-1.17%-5.69%-24.17%-20.97%-17.83%-10.54%43.24%86.54%
Amentum Holdings AMTM 6.10B Mid-cap-4.21%3.09%11.55%21.64%12.37%-5.18%-5.18%-5.18%
CBIZ CBZ 4.17B Mid-cap1.13%6.19%11.82%-12.02%-6.17%7.18%72.40%205.58%
Maximus MMS 4.11B Mid-cap-2.78%1.47%6.38%-6.26%-6.04%-22.05%10.73%-8.19%

Ownership & Short Interest

Insider Ownership i 1.36%
Institutional Ownership i 95.45%
Shares Short i 1M
Short Ratio i 3.72
Short % of Shares Outstanding i 3.52%
Average 10-Day Volume i 295K
Average 90-Day Volume i 360K

Dolby Laboratories Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Dolby Laboratories would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Dolby Laboratories reached a high of $89.66 (on January 30, 2025) and a low of $66.35 (on August 12, 2024).
Curious about Dolby Laboratories's size and valuation? Its market capitalization stands at 7.34B. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.86, and the forward P/E (looking ahead) is 20.00.
As for dividends, Dolby Laboratories isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at Dolby Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Cintas
CTAS
89.41BIndustrialsSpecialty Business Services17.94%110.70%
Copart
CPRT
44.56BIndustrialsSpecialty Business Services-10.54%43.24%
Amentum Holdings
AMTM
6.10BIndustrialsSpecialty Business Services-5.18%-5.18%
CBIZ
CBZ
4.17BIndustrialsSpecialty Business Services7.18%72.40%
Maximus
MMS
4.11BIndustrialsSpecialty Business Services-22.05%10.73%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Dolby Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.31%, the Debt to Equity ratio from the most recent quarter is 1.57, and its Gross Profit Margin stands at 90.30%.
Looking at Dolby Laboratories's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 1.40%, and quarterly earnings saw a YoY growth of -6.20%.
Wondering who owns Dolby Laboratories stock? Company insiders (like executives and directors) hold about 1.36% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 95.45%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.